Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals

International Journal of Obesity

Volumn 25, Issue 12, 2001, Pages 1759-1766

  Van Dielen, F M H ^a   Van't Veer, C ^b   Schols, A M ^a   Soeters, P B ^a   Buurman, W A ^b   Greve, J W M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acute phase proteins; Inflammatory markers; Leptin; Soluble TNF receptors

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR; LEPTIN; LIPOPOLYSACCHARIDE BINDING PROTEIN; OROSOMUCOID; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL;

ACUTE-PHASE PROTEINS; ADIPOSE TISSUE; ADULT; BODY MASS INDEX; FEMALE; HUMANS; INFLAMMATION; LEPTIN; MALE; OBESITY, MORBID; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035209720     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801825     Document Type: Article

References (59)

1. Multiple cytokines and acute inflammation raise mouse leptin levels: Potential role in inflammatory anorexia
2. Positional cloning of the mouse obese gene and its human homologue
3. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
4. Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus
5. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
6. Identification of targets of leptin action in rat hypothalamus
7. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat
8. Abnormal splicing of the leptin receptor in diabetic mice
9. Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice
10. Weight-reducing effects of the plasma protein encoded by the obese gene
11. Effects of the obese gene product on body weight regulation in ob/ob mice
12. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse
13. LPS-induced anorexia in leptin-deficient (ob/ob) and leptin receptor-deficient (db/db) mice
14. Leptin deficiency enhances sensitivity to endotoxin-induced lethality
15. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
16. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor
17. Health risks of obesity
18. Atherosclerosis - An inflammatory disease
19. Monoclonal antibody based ELISA for human SAA
20. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha
21. Tumor necrosis factor alpha: A key component of the obesity-diabetes link
22. Tumor necrosis factor alpha inhibits signaling from the insulin receptor
23. Leptin impairs metabolic actions of insulin in isolated rat adipocytes
24. Expression of plasminogen activator inhibitor-1 in human adipose tissue: A role for TNF-alpha?
25. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
26. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1
27. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
28. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
29. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein
30. Lipopolysaccharide toxicity-regulating proteins in bacteremia
31. Plasma leptin and insulin levels in weight-reduced obese women with normal body mass index: Relationships with body composition and insulin
32. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo
33. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia
34. LPS induced sTNF-Receptor release in vivo in a murine model: Investigation of the role of TNF, IL-1, LIF, IL-1, and IFNY
35. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors
36. Tumor necrosis factor: Function, release and clearance
37. Plasma concentrations of soluble TNF-alpha receptors in obese subjects
38. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects
39. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
40. Leptin regulates proinflammatory immune responses
41. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease
42. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response
43. The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells
44. Inflammatory mediators and their influence on haemostasis
45. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4
46. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
47. Inhibition of insulin receptor signaling by TNF: Potential role in obesity and non-insulin-dependent diabetes mellitus
48. Protection from obesity-induced insulin resistance in mice lacking tnf-alpha function
49. Risk factors for coronary heart disease and acute-phase proteins. A population-based study
50. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
51. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease
52. Impaired fibrinolysis and the risk for coronary heart disease
53. Plasma leptin concentrations and OB gene expression in subcutaneous-adipose tissue are not regulated acutely by physiological hyperinsulinaemia in lean and obese humans
54. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
55. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
56. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms
57. Tumor necrosis factor increases serum leptin levels in humans
58. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man
59. The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes